You have 9 free searches left this month | for more free features.

Tumors, Breast

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Tumors Trial

Not yet recruiting
  • Breast Tumors
    • (no location specified)
    Aug 2, 2023

    Breast Cancer Trial (CBD Oral, Control)

    Not yet recruiting
    • Breast Cancer
    • CBD Oral
    • Control
    • (no location specified)
    Nov 18, 2023

    Breast Cancer Trial in Sittard (Pintuition)

    Active, not recruiting
    • Breast Cancer
    • Pintuition
    • Sittard, Limburg, Netherlands
      Zuyderland Medical Center
    Sep 19, 2023

    HER2+ Advanced Breast Cancer, Other Solid Tumors Trial (ADCC-R-Epo-R T-cells + Trastuzumab, Erythropoietin beta, Fludarabine and

    Not yet recruiting
    • HER2+ Advanced Breast Cancer
    • Other Solid Tumors
    • ADCC-R-Epo-R T-cells + Trastuzumab
    • +2 more
    • (no location specified)
    Aug 31, 2023

    Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

    Not yet recruiting
    • Advanced Solid Tumor
    • +8 more
    • (no location specified)
    Nov 13, 2023

    Advanced Breast Cancer, Advanced Lung Cancer Trial (Tumor-infiltrating lymphocytes, IL-2)

    Not yet recruiting
    • Advanced Breast Cancer
    • Advanced Lung Cancer
    • Tumor-infiltrating lymphocytes
    • IL-2
    • (no location specified)
    Oct 26, 2023

    PIK3CA Mutation, Solid Tumor, Adult, HER2-negative Breast Cancer Trial (RLY-5836, Fulvestrant, Palbociclib)

    Not yet recruiting
    • PIK3CA Mutation
    • +7 more
    • (no location specified)
    Mar 7, 2023

    Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

    Not yet recruiting
    • Breast Cancer
    • +5 more
    • (no location specified)
    Jun 7, 2023

    Breast Cancer Trial in Nice (Metal wire, Radioactive Iodine Seed)

    Active, not recruiting
    • Breast Cancer
    • Metal wire
    • Radioactive Iodine Seed
    • Nice, France
      Centre Antoine LACASSAGNE
    Jan 19, 2023

    Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute

    Recruiting
    • Metastatic Colorectal Cancer
    • +4 more
    • Young TIL
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

    Active, not recruiting
    • Advanced Breast Cancer
    • +2 more
    • Talazoparib Tosylate
    • Stanford, California
      Stanford University Hospitals and Clinics
    Nov 16, 2022

    NSCLC, Breast Cancer, HNSCC Trial in Chang chun (YL202 should be intravenously infused)

    Not yet recruiting
    • NSCLC
    • +3 more
    • YL202 should be intravenously infused
    • Chang chun, Jilin, China
      Jilin Provincial Cancer Hospital
    Oct 25, 2023

    Malignant Tumor of Breast, Benign Breast Lumps, High-Risk Breast Cancer Trial (MRI scan)

    Not yet recruiting
    • Malignant Tumor of Breast
    • +2 more
    • MRI scan
    • (no location specified)
    Mar 23, 2022

    Advanced Breast Cancer, Treatment-Refractory Solid Tumors, Retinoblastoma Deficiency Trial in Providence (Palbociclib Oral

    Not yet recruiting
    • Advanced Breast Cancer
    • +6 more
    • Providence, Rhode Island
      Lifespan Cancer Institute
    Feb 1, 2023

    Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

    Not yet recruiting
    • Breast Cancer
    • +7 more
    • (no location specified)
    Sep 26, 2023

    Metastatic Breast Cancer, Solid Tumors Trial in Aurora (Alisertib, MLN0128)

    Completed
    • Metastatic Breast Cancer
    • Solid Tumors
    • Aurora, Colorado
      University of Colorado Cancer Center
    May 17, 2022

    Breast Cancer, HER2-positive Breast Cancer Trial in Los Angeles (Omit breast radiation)

    Not yet recruiting
    • Breast Cancer
    • HER2-positive Breast Cancer
    • Omit breast radiation
    • Los Angeles, California
      Cedars-Sinai Medical Center
    May 10, 2022

    Breast Cancer, Oligoprogressive, Head Neck Cancer Trial in Sacramento (Ablative local therapy)

    Recruiting
    • Breast Cancer
    • +4 more
    • Ablative local therapy
    • Sacramento, California
      University of California, Davis
    Oct 19, 2023

    Adult Soft Tissue Sarcoma, Non Small Cell Lung Cancer, Triple Negative Breast Cancer Trial in France (Ezabenlimab + BI907828)

    Not yet recruiting
    • Adult Soft Tissue Sarcoma
    • +4 more
    • Ezabenlimab + BI907828
    • Bordeaux, France
    • +5 more
    Oct 19, 2023

    Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)

    Recruiting
    • Triple Negative Breast Cancer
    • +2 more
    • Oklahoma City, Oklahoma
    • +1 more
    Nov 13, 2023

    Breast Cancer, Solid Tumor Trial in Shanghai (BL-B01D1)

    Recruiting
    • Breast Cancer
    • Solid Tumor
    • Shanghai, Shanghai, China
      Fudan University Cancer Hospital
    Jul 20, 2022

    Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC Trial (JAB-2485 (Aurora A inhibitor))

    Not yet recruiting
    • Solid Tumors
    • +4 more
    • JAB-2485 (Aurora A inhibitor)
    • (no location specified)
    Aug 4, 2022

    Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer Trial in Houston (IDE-161)

    Not yet recruiting
    • Advanced or Metastatic Solid Tumors
    • +4 more
    • Houston, Texas
      MD Anderson
    Mar 27, 2023

    Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

    Not yet recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Patritumab deruxtecan
    • (no location specified)
    May 9, 2023